Skip to main content

What the FDA labels say about taking them together

Auranofin and phenytoin

Auranofin's FDA label of November 8, 2025 names phenytoin in its drug interactions section; the phenytoin labels PlainMeds reads (2) do not name auranofin. The auranofin label: “Drug Interactions: In a single patient-report, there is the suggestion that concurrent administration of RIDAURA and phenytoin may have increased phenytoin blood levels.”

Check it at the source: the auranofin FDA label on DailyMed (effective November 8, 2025, Sebela Pharmaceuticals Inc.); the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.).

What does the auranofin label say about phenytoin?

Auranofin label, drug interactions

Drug Interactions: In a single patient-report, there is the suggestion that concurrent administration of RIDAURA and phenytoin may have increased phenytoin blood levels.

Source: FDA drug label (RIDAURA), NDA018689 (Legacy), as published by Sebela Pharmaceuticals Inc., effective November 8, 2025 (SPL set 43ba3de1-ab2e-06f6-e054-00144ff8d46c), via openFDA; the full label on DailyMed

What does the phenytoin label say about auranofin?

Phenytoin's label (effective October 15, 2024) and its 1 other brand-application label do not name auranofin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Auranofin generic labelers
29Phenytoin generic labelers
AuranofinPhenytoin
Labeled forRheumatoid arthritisSeizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)$24.85 per capsule 3 mg capsule$0.145 per capsule 100 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?